Overview

A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS)

Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of nipocalimab in participants with primary Sjogren's syndrome (pSS) versus placebo.
Phase:
Phase 2
Details
Lead Sponsor:
Janssen Research & Development, LLC